US equities
|
NVDA
$204.64
▼-4.22%
INTC
$65.76
▼-28.58%
MU
$884.74
▼-5.30%
AMZN
$240.35
▼-1.41%
AAPL
$344.63
▼-1.23%
SNDK
$1,150.89
▼-13.47%
AMD
$504.80
▼-10.88%
MSFT
$521.91
▼-1.55%
NVDA
$204.64
▼-4.22%
INTC
$65.76
▼-28.58%
MU
$884.74
▼-5.30%
AMZN
$240.35
▼-1.41%
AAPL
$344.63
▼-1.23%
SNDK
$1,150.89
▼-13.47%
AMD
$504.80
▼-10.88%
MSFT
$521.91
▼-1.55%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by PolarityTE, Inc.
PolarityTE to Attend H.C. Wainwright 23rd Annual Global Investment Conference and 2021 Cantor Virtual Global Healthcare Conference
September 07, 2021
From
PolarityTE, Inc.
Via
Business Wire
Tickers
PTE
PolarityTE Appoints Richard Hague as Chief Executive Officer and Elects David Seaburg to Board of Directors and Chair of Strategic Review Committee
September 02, 2021
From
PolarityTE, Inc.
Via
Business Wire
Tickers
PTE
PolarityTE Provides Update on U.S. FDA Investigational New Drug Application for SkinTE®
August 24, 2021
From
PolarityTE, Inc.
Via
Business Wire
Tickers
PTE
PolarityTE Reports Second Quarter Financial Results and Provides Business Update
August 12, 2021
From
PolarityTE, Inc.
Via
Business Wire
Tickers
PTE
PolarityTE to Report Second Quarter Financial Results on August 12, 2021
July 29, 2021
From
PolarityTE, Inc.
Via
Business Wire
Tickers
PTE
SkinTE® Met Primary and Secondary Endpoints in Final Analysis from Diabetic Foot Ulcer Trial
July 28, 2021
From
PolarityTE, Inc.
Via
Business Wire
Tickers
PTE
PolarityTE Submits Investigational New Drug Application for SkinTE® in Chronic Cutaneous Ulcers
July 26, 2021
From
PolarityTE, Inc.
Via
Business Wire
Tickers
PTE
PolarityTE Issues Statement About Potential Ticker Symbol Confusion
July 16, 2021
From
PolarityTE, Inc.
Via
Business Wire
Tickers
PTE
PolarityTE Receives Notice of Allowance for Chinese Patent
July 12, 2021
From
PolarityTE, Inc.
Via
Business Wire
Tickers
PTE
PolarityTE Reports First Quarter Results and Provides Business Update
May 13, 2021
From
PolarityTE, Inc.
Via
Business Wire
Tickers
PTE
PolarityTE Announces Diabetic Foot Ulcer Trial Met Primary and Secondary Endpoint
May 10, 2021
From
PolarityTE, Inc.
Via
Business Wire
Tickers
PTE
PolarityTE to Report First Quarter Financial Results on May 13, 2021
May 03, 2021
From
PolarityTE, Inc.
Via
Business Wire
Tickers
PTE
